Recursion Pharmaceuticals Growth, Revenue, Number of Employees and Funding

Location:

Salt Lake City, UT USA

Revenue:

$18.9M

Total Funding:

$141.3M

Industry:

Pharma

Founded:

2013

Lead Investor(s):

Square 1 Bank
Press

Industry Ranking

State Ranking

Growjo 10k Ranking

Recursion Pharmaceuticals Financials:

Recursion Pharmaceuticals's revenue is currently $18.9M per year.

Recursion Pharmaceuticals received $20.5M in venture funding in June 2018.

Recursion Pharmaceuticals has developed a powerful drug discovery platform involving millions of rapid, automated experiments and analysis to discover new therapeutics. Our platform has resulted in the massive parallelization of drug discovery. We have deployed this platform in pursuit of drugs for the treatment of rare genetic diseases. We partner or out-license these leads to major pharmaceutical companies early in development. Our horizontal business model focused on discovery accelerates our impact and reduces our costs by avoiding slow and costly in-house development, and allows us to spread risk across many new therapeutic opportunities.

keywords:Biotechnology,Healthcare,Pharmaceuticals

118

Number of Employees

$18.9M

Revenue (est)

15

Current Jobs

33%

Employee Growth %

$141.3M

Total Funding

N/A

Valuation

N/A

Accelerator

B2C

Type

Recursion Pharmaceuticals News

20-Mar-19 - How AI Is Finding New Cures in Old Drugs

Running in the same race as Pharnext are companies ranging from giants like Google and IBM to startups such as Insilico Medicine, Recursion Pharmaceuticals

20-Mar-19 - Global Metachromatic Leukodystrophy (MLD) Treatment Market 2019

Global Metachromatic Leukodystrophy (MLD) Treatment Market 2019 – ArmaGen Inc, GlaxoSmithKline Plc, Recursion Pharmaceuticals Inc,

18-Mar-19 - Pfenex Appoints Dr. Martin B. Brenner as Chief Scientific Officer

Most recently, Dr. Brenner served as the CSO at Recursion Pharmaceuticals, a company focused on accelerating drug discovery for rare

Recursion Pharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2015-12-08$2.6MUndisclosedArticle
2016-10-04$12.9MALux CapitalArticle
2016-11-23$2.2MAFelicis VenturesArticle
2017-02-10$4.0MUndisclosedSquare 1 BankArticle
2017-10-04$60.0MBData Collective (DCVC)Article
2018-06-06$20.5MUndisclosedSquare 1 BankArticle

Recursion Pharmaceuticals Executive Hires

DateNameTitleReference
2016-10-26John PereiraCOOArticle
2018-05-02Kevin LynchChief Business OfficerArticle
2018-05-16Phil CarpinoDir ChemistryArticle
2018-07-11Tina LarsonChief Operating OfficerArticle